Retrospective cohort analysis shows biologic therapies greatly improve outcomes in generalized pustular psoriasis, suggesting enhanced access is essential.
These findings provide robust real-world evidence that biologics significantly improve both acute and long-term outcomes in GPP, supporting their use as first-line therapy and underscoring the need to improve global access to these treatments.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: